2026 Asia Bioassay Conference
Incheon, South Korea | November 4-6, 2026
Registration Early Bird Prices:Prices increase end-of-day April 29, 2026.
3-Day Event
Includes:
- Bioassay Workshops
- Scientific Poster Session
- Two days of Podium Presentations
- Two networking events
Group Discounts (only applicable to Industry tickets):
Quick Links
November, 2026
Incheon, South Korea
Hybrid Conference
Deadlines
Abstract Submission: March 6, 2026
Poster Submission: Oct. 14, 2026
Next Price Increase: April 29, 2026
Registration Closes:
In-person closes Oct. 23, 2026
Virtual closes Oct. 30, 2026
Draft Agenda
Our Hybrid 2026 European Bioassay Conference draft agenda is here! Check the agenda for updates as we finalize our schedule.
Note: The official language of the conference is English. No simultaneous translation will be provided.
Participating Companies:
- CSL
- National Institute of Health Sciences
- Astellas Pharma Inc.
- Kyowa Kirin Co., Ltd.
- GreyRigge Associates
- Kodo Life Science
- Charles River Laboratories
- Richter BioLogics
- Svar Life Science
- Stegmann Systems
Hotel Information
A room block is being prepared for the 2026 Hybrid Asia Bioassay Conference. Check back for updates!
2026 Asia Bioassay Exhibitors
2026 Planning Committee
Gaurav Agrawal
Eurofins
Frank Fan
Promega Corporation
Chaohong (Mary) Hu
Independent Consultant
Xu-Rong Jiang
Bristol Myers Squibb
Laureen Little
BEBPA
Ayumi Takayanagi
Chugai Pharmaceutical
Andrew Thomson
GreyRigge Associates
Yukina Umemoto
Chugai Pharmaceutical